Drug Type Biological products |
Synonyms SMC-108 |
Target |
Action modulators |
Mechanism bFGF modulators(Fibroblast growth factor 2 modulators) |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
License Organization- |
Drug Highest PhaseDiscontinuedDiscovery |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Bone injury | Discovery | United States | - | |
Cartilage Diseases | Discovery | United States | - | |
Gastrointestinal Diseases | Discovery | United States | - | |
Heart Diseases | Discovery | United States | - | |
Multiple Sclerosis | Discovery | United States | - | |
Osteoarthritis | Discovery | United States | - | |
Scleroderma, Systemic | Discovery | United States | - | |
Wounds and Injuries | Discovery | United States | - |